A collection of mini theses that we have been thinking about.
We seek to invest in businesses that capture and own interesting data, turning it into long-term moats and venture-scale outcomes.
We seek to fund digital chronic care management solutions to manage disease symptoms and improve quality of life.
By capturing unique data through existing bioprocess workflows and employing AI to fully reimagine these workflows, we can enhance the robustness and efficiency of biomanufacturing operations.
We believe in two major AI opportunities - the first one is around unique data capture through existing workflows and the second is to use AI to fully reinvent the workflows.
We foresee a future in biobanking with emerging types of biological data and seamless sample management and exchange, all enhanced by a robust security and authenticity layer.
We see a future of diagnostics where both data and technology have strong roles to play.
